Medication Reviews by Clinical Pharmacists at Hospitals Lead to Improved Patient Outcomes: A Systematic Review

Basic and Clinical Pharmacology and Toxicology

Volumn 112, Issue 6, 2013, Pages 359-373

  Graabæk, Trine ^a   Kjeldsen, Lene Juel ^b  

^a Hospital South West Jutland ^*  (Denmark)

^b The Danish Research Unit for Hospital Pharmacy   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CINAHL; CLINICAL PHARMACY; COCHRANE LIBRARY; DRUG USE; EMBASE; HEALTH CARE QUALITY; HEALTH CARE UTILIZATION; HOSPITAL PATIENT; HUMAN; MEDICATION THERAPY MANAGEMENT; MEDLINE; OUTCOME ASSESSMENT; PHARMACIST; PRIORITY JOURNAL; SYSTEMATIC REVIEW;

DRUG PRESCRIPTIONS; HUMANS; INAPPROPRIATE PRESCRIBING; MEDICATION RECONCILIATION; PHARMACISTS; PHARMACY SERVICE, HOSPITAL; RANDOMIZED CONTROLLED TRIALS AS TOPIC; TREATMENT OUTCOME;

EID: 84878154893     PISSN: 17427835     EISSN: 17427843     Source Type: Journal    
DOI: 10.1111/bcpt.12062     Document Type: Article

References (157)

1. Gurwitz JH, Field TS, Harrold LR, Rothschild J, Debellis K, Seger AC et al. Incidence and preventability of adverse drug events among older persons in the ambulatory setting. JAMA 2003;289:1107-16.
2. Beijer HJM, de Blaey CJ. Hospitalisations caused by adverse drug reactions (ADR): a meta-analysis of observational studies. Pharm World Sci 2002;24:46-54.
3. Hakkarainen KM, Hedna K, Petzold M, Hägg S. Percentage of patients with preventable adverse drug reactions and preventability of adverse drug reactions - a meta-analysis. PLoS ONE 2012;7:e33236.
4. The audit commission. A spoonful of sugar. Medicines management in NHS hospitals. http://www.audit-commission.gov.uk/nationalstudies/health/other/Pages/aspoonfulofsugar.aspx. (last accessed 9 January 2012).
5. Blenkinsopp A, Bond C, Raynor DK. Medication reviews. Br J Clin Pharmacol 2012;74:573-80.
6. National Prescribing Centre. A guide to medication review. http://www.npc.nhs.uk/review_medicines/intro/resources/agtmr_web1.pdf. (last accessed 9 November 2012).
7. Chen T, Almeida Neto A. Exploring elements of interprofessional collaboration between pharmacists and physicians in medication review. Pharm World Sci 2007;29:574-6.
8. Spinewine A, Schmader KE, Barber N, Hughes C, Lapane KL, Swine C et al. Appropriate prescribing in elderly people: how well can it be measured and optimised? Lancet 2007;370:173-84.
9. Holland R, Desborough J, Goodyer L, Hall S, Wright D, Loke YK. Does pharmacist-led medication review help to reduce hospital admissions and deaths in older people? A systematic review and meta-analysis. Br J Clin Pharmacol 2008;65:303-16.
10. Royal S, Smeaton L, Avery AJ, Hurwitz B, Sheikh A. Interventions in primary care to reduce medication related adverse events and hospital admissions: systematic review and meta-analysis. Qual Saf Health Care 2006;15:23-31.
11. Melchiors A, Correr C, Venson R, Pontarolo R. An analysis of quality of systematic reviews on pharmacist health interventions. Int J Clin Pharm 2012;34:32-42.
12. Gillespie U, Alassaad A, Henrohn D, Garmo H, Hammarlund-Udenaes M, Toss H et al. A comprehensive pharmacist intervention to reduce morbidity in patients 80 years or older: a randomized controlled trial. Arch Intern Med 2009;169:894-900.
13. Bergkvist A, Midlov P, Hoglund P, Larsson L, Eriksson T. A multi-intervention approach on drug therapy can lead to a more appropriate drug use in the elderly. LIMM-Landskrona Integrated Medicines Management. J Eval Clin Pract 2009;15:660-7.
14. Hellstrom LM, Bondesson A, Hoglund P, Midlov P, Holmdahl L, Rickhag E et al. Impact of the Lund Integrated Medicines Management (LIMM) model on medication appropriateness and drug-related hospital revisits. Eur J Clin Pharmacol 2011;67:741-52.
15. Scullin C, Hogg A, Luo R, Scott MG, McElnay JC. Integrated medicines management - can routine implementation improve quality? J Eval Clin Pract 2012;18:807-15.
16. Merlin T, Weston A, Tooher R. Extending an evidence hierarchy to include topics other than treatment: revising the Australian 'levels of evidence'. BMC Med Res Methodol 2009;9:34.
17. Cochrane Effective Practice and Organisation of Care Review Group. EPOC resources. Data collection checklist and Risk of bias - EPOC specific. http://epoc.cochrane.org/epoc-resources. (last accessed 15 November 2012).
18. Austwick EA, Brown LC, Goodyear KH, Brooks DJ. Pharmacist's input into a palliative care clinic. Pharm J 2002;268:404-6.
19. Bremberg ER, Hising C, Nylén U, Ehrsson H, Eksborg S. An evaluation of pharmacist contribution to an oncology ward in a Swedish hospital. J Oncol Pharm Pract 2006;12:75-81.
20. Burden N. A comprehensive medication management program in the ambulatory surgery setting. J Perianesth Nurs 2007;22:40-6.
21. Canales PL, Dorson PG, Crismon ML. Outcomes assessment of clinical pharmacy services in a psychiatric inpatient setting. Am J Health Syst Pharm 2001;58:1309-16.
22. Clifford RM, Batty KT, Davis TME, Davis W, Stein G, Stewart G et al. A randomised controlled trial of a pharmaceutical care programme in high-risk diabetic patients in an outpatient clinic. Int J Pharm Pract 2002;10:85-9.
23. Dorevitch A, Aronzon R, Zilberman L. Medication maintenance of chronic schizophrenic out-patients by a psychiatric clinical pharmacist: 10-year follow-up study. J Clin Pharm Ther 1993;18:183-6.
24. Elliott RA, O'Callaghan CJ. Impact of hospitalisation on the complexity of older patients' medication regimens and potential for regimen simplification. J Pharm Pract Res 2011;41:21-5.
25. Fleming GF, Hogg A, Woods A, Scott MG, McElnay J. A hospital-based integrated medicines management model. Pharm J 2003;271:214-5.
26. Flood KL, Carroll MB, Le CV, Brown CJ. Polypharmacy in hospitalized older adult cancer patients: experience from a prospective, observational study of an Oncology-Acute care for elders unit. Am J Geriatr Pharmacother 2009;7:151-8.
27. Jarrett PG, Deschenes PJ, MacDonald EA, Thompson C. Pharmacy review rounds and medication appropriateness on a GEMU. Geriatr Today: J Can Geriatr Soc 2005;8:21-6.
28. Knight EL, Avorn J. Quality indicators for appropriate medication use in vulnerable elders. Ann Intern Med 2001;135:703-10.
29. Mirkov SR, Ball PA. Design and pilot of a medication review clinic in a dialysis centre. J Pharm Pract Res 2003;33:199-203.
30. Patel NP, Brandt CP, Yowler CJ. A prospective study of the impact of a critical care pharmacist assigned as a member of the multidisciplinary Burn Care Team. J Burn Care Res 2006;27:310-3.
31. Schenk RJ Jr, Schenk J. Integration of remote blood glucose meter upload technology into a clinical pharmacist medication therapy management service. J Diabetes Sci Technol 2011;5:188-91.
32. Spinewine A, Dhillon S, Mallet L, Tulkens PM, Wilmotte L, Swine C. Implementation of ward-based clinical pharmacy services in Belgium - description of the impact on a geriatric unit. Ann Pharmacother 2006;40:720-8.
33. Stell R, Bonollo M, Fiddes K, Dooley MJ. Successful integration of a clinical pharmacist into a disease management unit. J Pharm Pract Res 2008;38:132-6.
34. Sorensen L, Grobler MP, Roberts MS. Development of a quality use of medicines coding system to rate clinical pharmacists' medication review recommendations. Pharm World Sci 2003;25:212-7.
35. Taylor TL, Dupuis LL, Nicksy D, Girvan C. Clinical pharmacy services in a pediatric hematology/oncology clinic: a description and assessment. Can J Hosp Pharm 1999;52:18-23.
36. Terceros Y, Chahine-Chakhtoura C, Malinowski JE, Rickley WF. Impact of a pharmacy resident on hospital length of stay and drug-related costs. Ann Pharmacother 2007;41:742-8.
37. Valgus JM, Faso A, Gregory KM, Jarr S, Savage S, Caiola S et al. Integration of a clinical pharmacist into the hematology-oncology clinics at an academic medical center. Am J Health Syst Pharm 2011;68:613-9.
38. Vessal G. Detection of prescription errors by a unit-based clinical pharmacist in a nephrology ward. Pharm World Sci 2010;32:59-65.
39. Viktil KK, Blix HS, Moger TA, Reikvam A. Interview of patients by pharmacists contributes significantly to the identification of drug-related problems (DRPs). Pharmacoepidemiol Drug Saf 2006;15:667-74.
40. Virani A, Crown N. The impact of a clinical pharmacist on patient and economic outcomes in a child and adolescent mental health unit. Can J Hosp Pharm 2003;56:158-62.
41. Young A, Horsely J. A complete service model of medicines management offers patients continuity of care. Pharm Pract 2007;17:168-72.
42. Zaidi STR, Hassan Y, Postma MJ, Seiw Hain N. Impact of pharmacist recommendations on the cost of drug therapy in ICU patients at a Malaysian hospital. Pharm World Sci 2003;25:299-302.
43. Condren ME, Haase MR, Luedtke SA, Gaylor AS. Clinical activities of an academic pediatric pharmacy team. Ann Pharmacother 2004;38:574-8.
44. Gallagher PF, O'Connor MN, O'Mahony D. Prevention of potentially inappropriate prescribing for elderly patients: a randomized controlled trial using STOPP/START criteria. Clin Pharmacol Ther 2011;89:845-54.
45. Gandhi PJ, Smith BS, Tataronis GR, Maas B. Impact of a pharmacist on drug costs in a coronary care unit. Am J Health Syst Pharm 2001;58:497-503.
46. Guy J, Persaud J, Davies E, Harvey D. Drug errors: what role do nurses and pharmacists have in minimizing the risk? J Child Health Care 2003;7:277-90.
47. Karapinar-Carkit F, Borgsteede SD, Zoer J, Smit HJ, Egberts AC, van den Bemt PM. Effect of medication reconciliation with and without patient counseling on the number of pharmaceutical interventions among patients discharged from the hospital. Ann Pharmacother 2009;43:1001-10.
48. Kroenke K, Pinholt EM. Reducing polypharmacy in the elderly. A controlled trial of physician feedback. J Am Geriatr Soc 1990;38:31-6.
49. Lee AJ, Boro MS, Knapp KK, Meier JL, Korman NE. Clinical and economic outcomes of pharmacist recommendations in a Veterans Affairs medical center. Am J Health Syst Pharm 2002;59:2070-7.
50. Atayee RS, Best BM, Daniels CE. Development of an ambulatory palliative care pharmacist practice. J Palliat Med 2008;11:1077-82.
51. Blakey SA, Hixson-Wallace JA. Clinical and economic effects of pharmacy services in geriatric ambulatory clinic. Pharmacotherapy 2000;20:1198-203.
52. Bolas H, Brookes K, Scott M, McElnay J. Evaluation of a hospital-based community liaison pharmacy service in Northern Ireland. Pharm World Sci 2004;26:114-20.
53. Britton ML, Lurvey PL. Impact of medication profile review on prescribing in a general medicine clinic. Am J Hosp Pharm 1991;48:265-70.
54. Brooks AD, Rihani RS, Derus CL. Pharmacist membership in a medical group's diabetes health management program. Am J Health Syst Pharm 2007;64:617-21.
55. Bucci C, Jackevicius C, McFarlane K, Liu P. Pharmacist's contribution in a heart function clinic: patient perception and medication appropriateness. Can J Cardiol 2003;19:391-6.
56. Cowper PA, Weinberger M, Hanlon JT, Landsman PB, Samsa GP, Uttech KM et al. The cost-effectiveness of a clinical pharmacist intervention among elderly outpatients. Pharmacotherapy 1998;18:327-32.
57. Crotty M, Halbert J, Rowett D, Giles L, Birks R, Williams H et al. An outreach geriatric medication advisory service in residential aged care: a randomised controlled trial of case conferencing. Age Ageing 2004;33:612-7.
58. Daugherty KK, Kangas K. Enhancing pharmacists' recommendation process in an internal medicine resident clinic. J Am Pharm Assoc 2004;44:89-93.
59. Davis RG, Hepfinger CA, Sauer KA, Wilhardt MS. Retrospective evaluation of medication appropriateness and clinical pharmacist drug therapy recommendations for home-based primary care veterans. Am J Geriatr Pharmacother 2007;5:40-7.
60. DeName B, Divine H, Nicholas A, Steinke DT, Johnson CL. Identification of medication-related problems and health care provider acceptance of pharmacist recommendations in the DiabetesCARE program. J Am Pharm Assoc 2008;48:731-6.
61. Gattis WA, Hasselblad V, Whellan DJ, O'Connor CM. Reduction in heart failure events by the addition of a clinical pharmacist to the heart failure management team: results of the Pharmacist in Heart Failure Assessment Recommendation and Monitoring (PHARM) Study. Arch Intern Med 1999;159:1939-45.
62. Gourley GA, Portner TS, Gourley DR, Rigolosi EL, Holt JM, Solomon DK et al. Humanistic outcomes in the hypertension and COPD arms of a multicenter outcomes study. J Am Pharm Assoc 1998;38:586-97.
63. Grabe DW, Low CL, Bailie GR, Eisele G. Evaluation of drug-related problems in an outpatient hemodialysis unit and the impact of a clinical pharmacist. Clin Nephrol 1997;47:117-21.
64. Hugtenburg JG, Borgsteede SD, Beckeringh JJ. Medication review and patient counselling at discharge from the hospital by community pharmacists. Pharm World Sci 2009;31:630-7.
65. Isetts BJ, Schondelmeyer SW, Artz MB, Lenarz LA, Heaton AH, Wadd WB et al. Clinical and economic outcomes of medication therapy management services: the Minnesota experience. J Am Pharm Assoc 2008;48:203-11.
66. Jameson JP, VanNoord GR. Pharmacotherapy consultation on polypharmacy patients in ambulatory care. Ann Pharmacother 2001;35:835-40.
67. Johnson CL, Nicholas A, Divine H, Perrier DG, Blumenschein K, Steinke DT. Outcomes from DiabetesCARE: a pharmacist-provided diabetes management service. J Am Pharm Assoc 2008;48:722-30.
68. Krska J, Hansford D, Seymour DG, Farquharson J. Is hospital admission a sufficiently sensitive outcome measure for evaluating medication review services? A descriptive analysis of admissions within a randomised controlled trial. Int J Pharm Pract 2007;15:85-91.
69. Laucka PV, Webster WB, Kuch J. Pharmacist review to simplify medication regimens in a VAMC primary care clinic. J Pharm Technol 1996;12:62-6.
70. Lim WS, Low HN, Chan SP, Chen HN, Ding YY, Tan TL. Impact of a pharmacist consult clinic on a hospital-based geriatric outpatient clinic in Singapore. Ann Acad Med Singapore 2004;33:220-7.
71. Manley HJ, McClaran ML, Overbay DK, Wright MA, Reid GM, Bender WL et al. Factors associated with medication-related problems in ambulatory hemodialysis patients. Am J Kidney Dis 2003;41:386-93.
72. Munzenberger P, Emmanuel S, Heins M. The role of a pharmacist on the pediatric unit of a general hospital. Am J Hosp Pharm 1972;29:755-60.
73. Nazareth I, Burton A, Shulman S, Smith P, Haines A, Timberal H. A pharmacy discharge plan for hospitalized elderly patients - a randomized controlled trial. Age Ageing 2001;30:33-40.
74. Norton JL, Gibson DL. Establishing an outpatient anticoagulation clinic in a community hospital. Am J Health Syst Pharm 1996;53:1151-7.
75. Pai AB, Boyd A, Depczynski J, Chavez IM, Khan N, Manley H. Reduced drug use and hospitalization rates in patients undergoing hemodialysis who received pharmaceutical care: a 2-year, randomized, controlled study. Pharmacotherapy 2009;29:1433-40.
76. Raebel MA, Charles J, Dugan J, Carroll NM, Korner EJ, Brand DW et al. Randomized trial to improve prescribing safety in ambulatory elderly patients. J Am Geriatr Soc 2007;55:977-85.
77. Ruder AD, Smith DL, Madsen MT, Kass FH III. Is there a benefit to having a clinical oncology pharmacist on staff at a community oncology clinic? J Oncol Pharm Pract 2011;17:425-32.
78. Steele MA, Bess DT, Franse VL, Graber SE. Cost effectiveness of two interventions for reducing outpatient prescribing costs. DICP 1989;23:497-500.
79. Whellan DJ, Gaulden L, Gattis WA, Granger B, Russell SD, Blazing MA et al. The benefit of implementing a heart failure disease management program. Arch Intern Med 2001;161:2223-8.
80. Wilson S, Wahler R, Brown J, Doloresco F, Monte SV. Impact of pharmacist intervention on clinical outcomes in the palliative care setting. Am J Hosp Palliat Care 2011;28:316-20.
81. Zarowitz BJ, Stebelsky LA, Muma BK, Romain TM, Peterson EL. Reduction of high-risk polypharmacy drug combinations in patients in a managed care setting. Pharmacotherapy 2005;25:1636-45.
82. Bergkvist A, Midlov P, Hoglund P, Larsson L, Bondesson A, Eriksson T. Improved quality in the hospital discharge summary reduces medication errors - LIMM: Landskrona Integrated Medicines Management. Eur J Clin Pharmacol 2009;65:1037-46.
83. Brookes K, Scott MG, McConnell JB. The benefits of a hospital based community services liaison pharmacist. Pharm World Sci 2000;22:33-8.
84. Brown BK, Earnhart J. Pharmacists and their effectiveness in ensuring the appropriateness of the chronic medication regimens of geriatric inpatients. Consult Pharm 2004;19:432-6.
85. Brown JN, Barnes CL, Beasley B, Cisneros R, Pound M, Herring C. Effect of pharmacists on medication errors in an emergency department. Am J Health Syst Pharm 2008;65:330-3.
86. Buck TC, Brandstrup L, Brandslund I, Kampmann JP. The effects of introducing a clinical pharmacist on orthopaedic wards in Denmark. Pharm World Sci 2007;29:12-8.
87. Burnett KM, Scott MG, Fleming GF, Clark CM, McElnay JC. Effects of an integrated medicines management program on medication appropriateness in hospitalized patients. Am J Health Syst Pharm 2009;66:854-9.
88. Carcelero E, Tuset M, Martin M, De LE, Codina C, Miro J et al. Evaluation of antiretroviral-related errors and interventions by the clinical pharmacist in hospitalized HIV-infected patients. HIV Med 2011;12:494-9.
89. Chinwong S, Reid F, McGlynn S, Hudson S, Flapan A. The need for pharmaceutical care in the prevention of coronary heart disease: an exploratory study in acute myocardial infarction patients. Pharm World Sci 2004;26:96-101.
90. Cohen V, Jellinek SP, Likourezos A, Nemeth I, Paul T, Murphy D. Variation in medication information for elderly patients during initial interventions by emergency department physicians. Am J Health Syst Pharm 2008;65:60-4.
91. Costello JL, Torowicz DL, Yeh TS. Effects of a pharmacist-led pediatrics medication safety team on medication-error reporting. Am J Health Syst Pharm 2007;64:1422-6.
92. Falck KA, Darsey EH, Naughton MJ. Pharmacy interventions in a multidisciplinary pediatric intensive care unit. J Pediatr Pharm Pract 1997;2:162-7.
93. Follin SL, Kwong NM. Enhancement of a pharmacy consultation program on a transitional care unit. Am J Health Syst Pharm 2000;57:1990-3.
94. Frei P, Huber LC, Simon RW, Bonani M, Luscher TF. Insufficient medication documentation at hospital admission of cardiac patients: a challenge for medication reconciliation. J Cardiovasc Pharmacol 2009;54:497-501.
95. Galindo C, Olive M, Lacasa C, Martinez J, Roure C, Llado M et al. Pharmaceutical care: pharmacy involvement in prescribing in an acute-care hospital. Pharm World Sci 2003;25:56-64.
96. Gardner B, Graner K. Pharmacists' medication reconciliation-related clinical interventions in a children's hospital. Jt Comm J Qual Patient Saf 2009;35:278-82.
97. George LJW, Senturk-Raif R, Hodgkinson MR, Emmerton M, Larmour I. Impact of a surgical preadmission clinic pharmacist on the quality of medication management from preadmission to discharge: a randomised controlled study. J Pharm Pract Res 2011;41:212-6.
98. Gibson JT, Alexander VL, Newton DS. Influence on medication therapy of increased patient services by pharmacists in a pediatric hospital. Am J Hosp Pharm 1975;32:495-500.
99. Gleason KM, McDaniel MR, Feinglass J, Baker DW, Lindquist L, Liss D et al. Results of the Medications at Transitions and Clinical Handoffs (MATCH) study: an analysis of medication reconciliation errors and risk factors at hospital admission. J Gen Intern Med 2010;25:441-7.
100. Jacklin A, Patel K, Almossawi O. A discharge pharmacist service improves the timeliness, quality and cost of discharge. Pharm Pract 2001;11:100-2.
101. Klopotowska JE, Kuiper R, van Kan HJ, de Pont AC, Dijkgraaf MG, Lie AH et al. On-ward participation of a hospital pharmacist in a Dutch intensive care unit reduces prescribing errors and related patient harm: an intervention study. Crit Care 2010;14:R174.
102. Koren G, Reich A, Hales B. Use of clinical pharmacists to prevent medication errors in children. J Pharm Technol 1991;7:219-21.
103. Kucukarslan SN, Peters M, Mlynarek M, Nafziger DA. Pharmacists on rounding teams reduce preventable adverse drug events in hospital general medicine units. Arch Intern Med 2003;163:2014-8.
104. Ling JM, Mike LA, Rubin J, Abraham P, Howe A, Patka J et al. Documentation of pharmacist interventions in the emergency department. Am J Health Syst Pharm 2005;62:1793-7.
105. McMullin ST, Hennenfent JA, Ritchie DJ, Huey WY, Lonergan TP, Schaiff RA et al. A prospective, randomized trial to assess the cost impact of pharmacist-initiated interventions. Arch Intern Med 1999;159:2306-9.
106. Mehta BH, Rodis JL, Nahata MC, Bennett MS. Advancing patient care through innovative practice: the Clinical Partners Program. Am J Health Syst Pharm 2005;62:2501-7.
107. Miller G, Franklin BD, Jacklin A. Including pharmacists on consultant-led ward rounds: a prospective non-randomised controlled trial. Clin Med 2011;11:312-6.
108. Moffett BS, Mott AR, Nelson DP, Gurwitch KD. Medication dosing and renal insufficiency in a pediatric cardiac intensive care unit: impact of pharmacist consultation. Pediatr Cardiol 2008;29:744-8.
109. Murray MD, Young J, Hoke S, Tu W, Weiner M, Morrow D et al. Pharmacist intervention to improve medication adherence in heart failure: a randomized trial. Ann Intern Med 2007;146:714-25.
110. Poh EW, Nigro O, Avent ML, Doecke CJ. Pharmaceutical reforms: clinical pharmacy ward service versus a medical team model. J Pharm Pract Res 2009;39:176-80.
111. Poulson LK, Nissen L, Coombes I. Pharmaceutical review using telemedicine - a before and after feasibility study. J Telemed Telecare 2010;16:95-9.
112. Rabi SM, Dahdal WY. Implementation of a pharmacist resident medication reconciliation program. Pharm Educ 2007;7:351-7.
113. Rainville EC. Impact of pharmacist interventions on hospital readmissions for heart failure. Am J Health Syst Pharm 1999;56:1339-42.
114. Smith L, McGowan L, Moss-Barclay C, Wheater J, Knass D, Chrystyn H. An investigation of hospital generated pharmaceutical care when patients are discharged home from hospital. Br J Clin Pharmacol 1997;44:163-5.
115. Stowasser DA, Collins DM, Stowasser M. A randomised controlled trial of medication liaison services - patient outcomes. J Pharm Pract Res 2002;32:133-40.
116. Tamai IY, Rubenstein LZ, Josephson KR, Yamauchi JA. Impact of computerized drug profiles and a consulting pharmacist on outpatient prescribing patterns: a clinical trial. Drug Intell Clin Pharm 1987;21:890-5.
117. Varma SP, McElnay JCP, Hughes CMP, Passmore PAM, Varma MP. Pharmaceutical care of patients with congestive heart failure: interventions and outcomes. Pharmacotherapy 1999;19:860-9.
118. Vasileff HM, Whitten LE, Pink JA, Goldsworthy SJ, Angley MT. The effect on medication errors of pharmacists charting medication in an emergency department. Pharm World Sci 2009;31:373-9.
119. Aburuz SM, Bulatova NR, Yousef AM, Al-Ghazawi MA, Alawwa IA, Al-Saleh A. Comprehensive assessment of treatment related problems in hospitalized medicine patients in Jordan. Int J Clin Pharm 2011;33:501-11.
120. Al Salmi Z. Clinical audit of pharmaceutical care provided by a clinical pharmacist in cardiology and infectious disease in-patients at the Royal Hospital, Muscat/Oman. Oman Med J 2009;24:89-94.
121. Bergkvist Christensen A, Holmbjer L, Midlov P, Hoglund P, Larsson L, Bondesson A et al. The process of identifying, solving and preventing drug related problems in the LIMM-study. Int J Clin Pharm 2011;33:1010-8.
122. Bladh L, Ottosson E, Karlsson J, Klintberg L, Wallerstedt SM. Effects of a clinical pharmacist service on health-related quality of life and prescribing of drugs: a randomised controlled trial. BMJ Qual Saf 2011;20:738-46.
123. Blix HS, Viktil KK, Moger TA, Reikvam A. Characteristics of drug-related problems discussed by hospital pharmacists in multidisciplinary teams. Pharm World Sci 2006;28:152-8.
124. Boso-Ribelles V, Montero-Hernandez M, Font-Noguera I, Hernandez-Martin J, Martin-Ciges ES, Poveda-Andres JL. Evaluation of a plan for cardiology medication reconciliation on admission, and patient information at discharge, in a teaching hospital. EJHP Practice 2011;17:2011-30.
125. Castelino RL, Sathvik BS, Parthasarathi G, Gurudev KC, Shetty MS, Narahari MG. Prevalence of medication-related problems among patients with renal compromise in an Indian hospital. J Clin Pharm Ther 2011;36:481-7.
126. Cerulli J, Malone M. Assessment of drug-related problems in clinical nutrition patients. JPEN J Parenter Enteral Nutr 1999;23:218-21.
127. Chan DS, Kotzin DA. Adult vs pediatric clinical intervention trends: a four year, retrospective report. J Pediatr Pharm Pract 1998;3:144-9.
128. Dooley MJ, Allen KM, Doecke CJ, Galbraith KJ, Taylor GR, Bright J et al. A prospective multicentre study of pharmacist initiated changes to drug therapy and patient management in acute care government funded hospitals. Br J Clin Pharmacol 2004;57:513-21.
129. Dorevitch A, Perl E. The impact of clinical pharmacy intervention in a psychiatric hospital. J Clin Pharm Ther 1996;21:45-8.
130. Fertleman M, Barnett N, Patel T. Improving medication management for patients: the effect of a pharmacist on post-admission ward rounds. Qual Saf Health Care 2005;14:207-11.
131. Fertleman M, Barnett N, Patel T. Erratum: Improving medication management for patients: the effect of a pharmacist on post-admission ward rounds. Qual Saf Health Care 2005;14:209.
132. Khalili H, Farsaei S, Rezaee H, Dashti-Khavidaki S. Role of clinical pharmacists' interventions in detection and prevention of medication errors in a medical ward. Int J Clin Pharm 2011;33:281-4.
133. Kjeldsen LJ, Olesen C, Truelshøj T, Nielsen LB. Quality assurance of medical treatment - an approach by Danish clinical pharmacists. EJHP Practice 2011;17:31-4.
134. Krupicka MI, Bratton SL, Sonnenthal K, Goldstein B. Impact of a pediatric clinical pharmacist in the pediatric intensive care unit. Crit Care Med 2002;30:919-21.
135. Lada P, Delgado G Jr. Documentation of pharmacists' interventions in an emergency department and associated cost avoidance. Am J Health Syst Pharm 2007;64:63-8.
136. Laivenieks N, McCaul K, O'Brodovich M. Clinical pharmacy services provided to an emergency department. Can J Hosp Pharm 1992;45:113-5.
137. Lal LS, Anassi EO, McCants E. Documentation of the first steps of pediatric pharmaceutical care in a county hospital. Hosp Pharm 1995;30:1107-8.
138. Lipton HL, Bero LA, Bird JA, McPhee SJ. The impact of clinical pharmacists' consultations on physicians' geriatric drug prescribing. A randomized controlled trial. Med Care 1992;30:646-58.
139. Lisby M, Thomsen A, Nielsen LP, Lyhne NM, Breum-Leer C, Fredberg U et al. The effect of systematic medication review in elderly patients admitted to an acute ward of internal medicine. Basic Clin Pharmacol Toxicol 2010;106:422-7.
140. Mortimer CDPM, Emmerton LBHPM, Lum EBM. The impact of an aged care pharmacist in a department of emergency medicine. J Eval Clin Pract 2011;17:478-85.
141. Munk CL, Bendixen HK, Kjeldsen LJ. Medication review with a focus on fracture prophylaxis among patients suffering collum femoris fractures. EJHP Practice 2011;17:26-30.
142. Mutnick AH, Sterba KJ, Peroutka JA, Sloan NE, Beltz EA, Sorenson MK. Cost savings and avoidance from clinical interventions. Am J Health Syst Pharm 1997;54:392-6.
143. Nesbit TW, Shermock KM, Bobek MB, Capozzi DL, Flores PA, Leonard MC et al. Implementation and pharmacoeconomic analysis of a clinical staff pharmacist practice model. Am J Health Syst Pharm 2001;58:784-90.
144. O'Dell KM, Kucukarslan SN. Impact of the clinical pharmacist on readmission in patients with acute coronary syndrome. Ann Pharmacother 2005;39:1423-7.
145. Pham DQ. Evaluating the impact of clinical interventions by PharmD students on internal medicine clerkships: the results of a 3 year study. Ann Pharmacother 2006;40:1541-5.
146. Scullin C, Scott MG, Hogg A, McElnay JC. An innovative approach to integrated medicines management. J Eval Clin Pract 2007;13:781-8.
147. Spinewine A, Swine C, Dhillon S, Lambert P, Nachega JB, Wilmotte L et al. Effect of a collaborative approach on the quality of prescribing for geriatric inpatients: a randomized, controlled trial. J Am Geriatr Soc 2007;55:658-65.
148. Strong DK, Tsang GW. Focus and impact of pharmacists' interventions. Can J Hosp Pharm 1993;46:101-8.
149. Nkansah N, Mostovetsky O, Yu C, Chheng T, Beney J, Bond CM et al. Effect of outpatient pharmacists' non-dispensing roles on patient outcomes and prescribing patterns. Cochrane Database Syst Rev 2010;7:CD000336.
150. Blades S, Eccles M, McColl E, Campbell M. Understanding the appropriateness of prescribing in primary care. Eur J Gen Pract 1998;4:60-4.
151. Andersen M. Is it possible to measure prescribing quality using only prescription data? Basic Clin Pharmacol Toxicol 2006;98:314-9.
152. Guyatt GH, Feeny DH, Patrick DL. Measuring health-related quality of life. Ann Intern Med 1993;118:622-9.
153. Corsonello A, Pedone C, Incalzi RA. Age-related pharmacokinetic and pharmacodynamic changes and related risk of adverse drug reactions. Curr Med Chem 2010;17:571-84.
154. Onder G, Lattanzio F, Battaglia M, Cerullo F, Sportiello R, Bernabei R et al. The risk of adverse drug reactions in older patients: beyond drug metabolism. Curr Drug Metab 2011;12:647-51.
155. Strand LM, Morley PC, Cipolle RJ, Ramsey R, Lamsam GD. Drug-related problems: their structure and function. DICP 1990;24:1093-7.
156. Pharmaceutical Care Network Europe (PCNE). Classification for Drug related problems V5.01. http://www.pcne.org/dokumenter/DRP/PCNE%20classification%20V5.01.pdf. (last accessed 19 November 2012).
157. Task Force on Medicines Partnership and the National Collaborative Medicines Management Services Programme. Room for review: a guide to medication review: the agenda for patients, practitioners and managers. http://www.npc.nhs.uk/review_medicines/intro/resources/room_for_review.pdf. (last accessed 30 March 2012).